Abstract
One of the first applications of peptide arrays in general and those prepared by SPOT synthesis in particular was the mapping of antibody epitopes. In this article the diverse applications in this field are described. Different types of peptide libraries such as peptide scans, substitution analyses, truncation and deletion libraries as well as combinatorial and randomly generated libraries are briefly covered. Furthermore, their applications for antibody epitope mapping are described. These are: (i) identification of antigenic determinants within protein sequences for monoclonal and polyclonal antibodies, (ii) identification of key residues for binding, mapping of linear and discontinuous binding sites, (iii) paratope mapping, (iv) identification of mimotopes, and finally (v) the profiling of complex (auto)antibody signatures in biological fluids such as human or mice sera to identify novel biomarkers for e.g. cancer, allergy, infectious and autoimmune diseases.
Keywords: Antibody, antigen, diagnostics, epitope mapping, peptide library, peptide microarray, peptide scan, SPOT synthesis
Mini-Reviews in Organic Chemistry
Title: Peptide Arrays for the Analysis of Antibody Epitope Recognition Patterns
Volume: 8 Issue: 2
Author(s): Ulf Reimer, Ulrich Reineke and Mike Schutkowski
Affiliation:
Keywords: Antibody, antigen, diagnostics, epitope mapping, peptide library, peptide microarray, peptide scan, SPOT synthesis
Abstract: One of the first applications of peptide arrays in general and those prepared by SPOT synthesis in particular was the mapping of antibody epitopes. In this article the diverse applications in this field are described. Different types of peptide libraries such as peptide scans, substitution analyses, truncation and deletion libraries as well as combinatorial and randomly generated libraries are briefly covered. Furthermore, their applications for antibody epitope mapping are described. These are: (i) identification of antigenic determinants within protein sequences for monoclonal and polyclonal antibodies, (ii) identification of key residues for binding, mapping of linear and discontinuous binding sites, (iii) paratope mapping, (iv) identification of mimotopes, and finally (v) the profiling of complex (auto)antibody signatures in biological fluids such as human or mice sera to identify novel biomarkers for e.g. cancer, allergy, infectious and autoimmune diseases.
Export Options
About this article
Cite this article as:
Reimer Ulf, Reineke Ulrich and Schutkowski Mike, Peptide Arrays for the Analysis of Antibody Epitope Recognition Patterns, Mini-Reviews in Organic Chemistry 2011; 8 (2) . https://dx.doi.org/10.2174/157019311795177835
DOI https://dx.doi.org/10.2174/157019311795177835 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
Call for Papers in Thematic Issues
Applications of Molecular Descriptors in Physicochemical Properties Research of Organic Compounds
Chemical graph theory is concerned with all aspects of the application of graph theory to various areas of chemistry, including organic, theoretical, mathematical, and computational chemistry, as well as in bioinformatics and computational biology. By the use of the term chemical it is emphasized that one is allowed in chemical ...read more
Navigating the 2D Universe in Organic Chemistry
This special issue explores the transformative impact of two-dimensional (2D) materials on the realm of organic chemistry, unraveling new possibilities for synthesis, functionalization, and applications of organic compounds. Focused on the unique chemistry within this novel dimension, the issue highlights breakthroughs in the field of 2D organic chemistry. Contributions are ...read more
Small Molecules, Big Impact: Pioneering Approaches in Anti-inflammatory Care
This thematic issue is dedicated to the latest advancements and research breakthroughs in the realm of anti-inflammatory pharmacotherapy. With inflammation playing a critical role in numerous chronic conditions such as cardiovascular diseases, diabetes, and autoimmune disorders, there is an urgent need for more targeted, effective, and safer anti-inflammatory treatments. This ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Monoclonal Antibodies: New Therapeutic Agents for Autoimmune Hemolytic Anemia?
Endocrine, Metabolic & Immune Disorders - Drug Targets Local Treatment for Lymphoid Malignancies of the Eye
Anti-Cancer Agents in Medicinal Chemistry Phosphoinositide 3-Kinase Gamma (PI3Kγ) Inhibitors for the Treatment of Inflammation and Autoimmune Disease
Recent Patents on Inflammation & Allergy Drug Discovery NF-κB, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Tolerance in the Absence of Autoantigen
Endocrine, Metabolic & Immune Disorders - Drug Targets Therapeutic Approach to Multiple Sclerosis by Novel Oral Drugs
Recent Patents on Inflammation & Allergy Drug Discovery The Use of Mesenchymal Stem Cells for the Treatment of Autoimmunity: From Animals Models to Human Disease
Current Drug Targets Design and Delivery of Therapeutic siRNAs: Application to MERS-Coronavirus
Current Pharmaceutical Design Natural Killer T Cells and Autoimmune Disease
Current Molecular Medicine Helper T Cells Point the Way to Specific Immunotherapy for Autoimmune Disease
Cardiovascular & Hematological Disorders-Drug Targets Polyreactive Antibodies in Anti-HIV-1 Responses
Current Molecular Medicine Identification of Expressed miRNAs in Human Rheumatoid Arthritis Using Computational Approach – Discovery of a New miR-7167 from Human
MicroRNA From Cannabis to Endocannabinoids in Multiple Sclerosis: A Paradigm of Central Nervous System Autoimmune Diseases
Current Drug Targets - CNS & Neurological Disorders The Interleukin-17/Interleukin-22 Innate Axis in the Gut as a New Drug Target in Allergic-Inflammatory and Autoimmune Diseases. A Working Hypothesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Acquired Hemophilia as Initial Presentation in a Patient with Systemic Lupus Erythematosus
Current Rheumatology Reviews Tissue-specific Glucocorticoid Signaling May Determine the Resistance Against Glucocorticoids in Autoimmune Diseases
Current Medicinal Chemistry Treatment of Central Nervous System Involvement Associated with Primary Sjogrens Syndrome
Current Pharmaceutical Design Genetic and Pharmacological Modulation of Dendritic Cell-T Cell Interactions as a Therapeutic Strategy for Systemic Lupus Erythematosus
Current Gene Therapy Inhibition of Type 1 Diabetes Development by Vitamin D Receptor Agonists
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Gene Therapy Using IL-12 Family Members in Infection, Auto-Immunity, and Cancer
Current Gene Therapy